Bernard D. Gary

1.7k total citations
40 papers, 1.3k citations indexed

About

Bernard D. Gary is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Bernard D. Gary has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 23 papers in Organic Chemistry and 18 papers in Pharmacology. Recurrent topics in Bernard D. Gary's work include Phosphodiesterase function and regulation (19 papers), Inflammatory mediators and NSAID effects (13 papers) and Chemical synthesis and alkaloids (9 papers). Bernard D. Gary is often cited by papers focused on Phosphodiesterase function and regulation (19 papers), Inflammatory mediators and NSAID effects (13 papers) and Chemical synthesis and alkaloids (9 papers). Bernard D. Gary collaborates with scholars based in United States, Egypt and Germany. Bernard D. Gary's co-authors include Gary A. Piazza, Heather N. Tinsley, Adam B. Keeton, Alireza Abadi, Yonghe Li, Robert C. Reynolds, Wenyan Lü, Li Nan, Jochen Lehmann and William E. Grizzle and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Bernard D. Gary

40 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernard D. Gary United States	20	749	454	368	200	117	40	1.3k
Heather N. Tinsley United States	18	775 1.0×	383 0.8×	361 1.0×	168 0.8×	115 1.0×	36	1.3k
Adam B. Keeton United States	25	1.1k 1.5×	451 1.0×	368 1.0×	349 1.7×	155 1.3×	84	1.8k
Ching-Shih Chen United States	11	468 0.6×	217 0.5×	432 1.2×	180 0.9×	237 2.0×	12	1.1k
Jennie L. Williams United States	21	475 0.6×	102 0.2×	411 1.1×	232 1.2×	160 1.4×	40	1.2k
Gerhard Sperl United States	9	567 0.8×	162 0.4×	770 2.1×	268 1.3×	432 3.7×	15	1.4k
Peppi Prasit United States	21	592 0.8×	242 0.5×	189 0.5×	126 0.6×	49 0.4×	44	1.2k
Linda C. Hsi United States	21	628 0.8×	108 0.2×	478 1.3×	154 0.8×	189 1.6×	32	1.4k
Gillian Hawcroft United Kingdom	15	447 0.6×	69 0.2×	568 1.5×	277 1.4×	276 2.4×	17	1.2k
N S Paranka United States	8	334 0.4×	118 0.3×	766 2.1×	253 1.3×	425 3.6×	10	1.1k
Marie‐Claude Carrière Canada	13	275 0.4×	215 0.5×	407 1.1×	77 0.4×	143 1.2×	14	927

Countries citing papers authored by Bernard D. Gary

Since Specialization

Citations

This map shows the geographic impact of Bernard D. Gary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard D. Gary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard D. Gary more than expected).

Fields of papers citing papers by Bernard D. Gary

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard D. Gary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard D. Gary. The network helps show where Bernard D. Gary may publish in the future.

Co-authorship network of co-authors of Bernard D. Gary

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard D. Gary. A scholar is included among the top collaborators of Bernard D. Gary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard D. Gary. Bernard D. Gary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tinsley, Heather N., Bini Mathew, Yulia Maxuitenko, et al.. (2023). Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats. Cancers. 15(3). 646–646. 5 indexed citations

Abdel‐Rahman, Hamdy M., Mohamed Abdel‐Aziz, Heather N. Tinsley, et al.. (2015). Design and Synthesis of Substituted Pyridazinone‐1‐Acetylhydrazones as Novel Phosphodiesterase 4 Inhibitors. Archiv der Pharmazie. 349(2). 104–111. 12 indexed citations

Aboul‐Fadl, Tarek, Kevin Lee, Li Nan, et al.. (2014). Novel non-cyclooxygenase inhibitory derivatives of naproxen for colorectal cancer chemoprevention. Medicinal Chemistry Research. 23(9). 4177–4188. 20 indexed citations

Abdel‐Rahman, Hamdy M., Mohamed Abdel‐Aziz, Joshua C. Canzoneri, Bernard D. Gary, & Gary A. Piazza. (2014). Novel Quinazolin‐4(3H)‐one/Schiff Base Hybrids as Antiproliferative and Phosphodiesterase 4 Inhibitors: Design, Synthesis, and Docking Studies. Archiv der Pharmazie. 347(9). 650–657. 14 indexed citations

Abdel‐Halim, Mohammad, Adam B. Keeton, Evrim Gurpinar, et al.. (2013). Trisubstituted and tetrasubstituted pyrazolines as a novel class of cell-growth inhibitors in tumor cells with wild type p53. Bioorganic & Medicinal Chemistry. 21(23). 7343–7356. 5 indexed citations

Gary, Bernard D., et al.. (2013). Design of Novel β‐Carboline Derivatives with Pendant 5‐Bromothienyl and Their Evaluation as Phosphodiesterase‐5 Inhibitors. Archiv der Pharmazie. 346(1). 23–33. 14 indexed citations

Awadallah, Fadi M., Gary A. Piazza, Bernard D. Gary, Adam B. Keeton, & Joshua C. Canzoneri. (2013). Synthesis of some dihydropyrimidine-based compounds bearing pyrazoline moiety and evaluation of their antiproliferative activity. European Journal of Medicinal Chemistry. 70. 273–279. 48 indexed citations

Arora, Ritu, Bernard D. Gary, Steven McClellan, et al.. (2013). Abstract 5571: Antitumor activity of a novel natural therapeutic agent against triple negative breast cancer.. Cancer Research. 73(8_Supplement). 5571–5571. 1 indexed citations

Abdelfattah, Mohamed A. O., et al.. (2012). Four-Component Synthesis of 1,2-Dihydropyridine Derivatives and their Evaluation as Anticancer Agents. Medicinal Chemistry. 8(3). 392–400. 21 indexed citations

10.

Gao, Lin, Qinghua Cui, Bernard D. Gary, et al.. (2012). Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs. Oncogene. 31(48). 4979–4986. 58 indexed citations

11.

Gary, Bernard D., Alexandra M. Fajardo, Heather N. Tinsley, et al.. (2012). Exploring the PDE5 H-pocket by ensemble docking and structure-based design and synthesis of novel β-carboline derivatives. European Journal of Medicinal Chemistry. 57. 329–343. 19 indexed citations

12.

Tinsley, Heather N., Bernard D. Gary, Adam B. Keeton, et al.. (2011). Inhibition of PDE5 by Sulindac Sulfide Selectively Induces Apoptosis and Attenuates Oncogenic Wnt/β-Catenin–Mediated Transcription in Human Breast Tumor Cells. Cancer Prevention Research. 4(8). 1275–1284. 88 indexed citations

13.

Abadi, Alireza, Bernard D. Gary, Heather N. Tinsley, Gary A. Piazza, & Mohammad Abdel‐Halim. (2010). Synthesis, molecular modeling and biological evaluation of novel tadalafil analogues as phosphodiesterase 5 and colon tumor cell growth inhibitors, new stereochemical perspective. European Journal of Medicinal Chemistry. 45(4). 1278–1286. 41 indexed citations

14.

Gary, Bernard D., et al.. (2010). Design, Synthesis and Structure–Activity Relationship of Functionalized Tetrahydro‐β‐carboline Derivatives as Novel PDE5 Inhibitors. Archiv der Pharmazie. 344(3). 149–157. 25 indexed citations

15.

Gary, Bernard D., et al.. (2010). A Novel Access to Arylated and Heteroarylated Beta-Carboline Based PDE5 Inhibitors. Medicinal Chemistry. 6(6). 374–387. 5 indexed citations

16.

Piazza, Gary A., Adam B. Keeton, Heather N. Tinsley, et al.. (2010). NSAIDs: Old Drugs Reveal New Anticancer Targets. Pharmaceuticals. 3(5). 1652–1667. 49 indexed citations

17.

Abadi, Alireza, Tamer M. Ibrahim, Khaled A. M. Abouzid, et al.. (2009). Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors. Bioorganic & Medicinal Chemistry. 17(16). 5974–5982. 87 indexed citations

18.

Abadi, Alireza, et al.. (2009). Discovery of colon tumor cell growth inhibitory agents through a combinatorial approach. European Journal of Medicinal Chemistry. 45(1). 90–97. 54 indexed citations

19.

Abadi, Alireza, Bernard D. Gary, Jose Thaiparambil, et al.. (2009). ChemInform Abstract: Synthesis of Novel Tadalafil Analogues and Their Evaluation as Phosphodiesterase Inhibitors and Anticancer Agents.. ChemInform. 40(52). 1 indexed citations

20.

Gary, Bernard D., et al.. (2004). Interaction of Nkx3.1 and p27kip1 in Prostate Tumor Initiation. American Journal Of Pathology. 164(5). 1607–1614. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact